STAT+: Biotech investor Eli Casdin on biotech’s bad December
Biotech investors are having some not-so-happy holidays.
In the last few months, several major funds have reportedly seen double-digit drops in their biotech portfolios’ value — leading some to wonder if the sector’s remarkable run is really, finally over this time.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Biotech investor Eli Casdin on biotech’s bad December »
